Compare DexCom, Inc. (DXCM) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Direxion Daily TSLA Bull 2X Shares — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Direxion Daily TSLA Bull 2X Shares trades at $10.39 (market cap $3.97B). The key difference: DexCom, Inc. is far larger — about 8× Direxion Daily TSLA Bull 2X Shares's market cap, and DexCom, Inc. is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.
| DXCM | TSLL | |
|---|---|---|
Market Cap | $31.86B | $3.97B |
Volume | 3,607,070 | 38,458,237 |
Sector | Health | Leveraged / Inverse |
52-Week High | $92.34 | $23.03 |
52-Week Low | $54.84 | $6.74 |
Typical Hold Time | 62 Days | 15 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
TSLL (Direxion Daily TSLA Bull 2X Shares ETF) trades at $10.43, up 2.76% with neutral technical signals. The leveraged ETF tracks Tesla's daily performance, showing recent strength tied to Tesla's Cybercab event anticipation. Moving averages indicate bullish momentum while oscillators remain neutral, with RSI suggesting potential overbought conditions at shorter timeframes.
As a leveraged ETF, TSLL carries amplified risk from Tesla's volatility and daily reset mechanics. Recent news highlights both opportunity from Tesla catalysts and structural risks where investors can lose money even when Tesla rises. The ETF's performance depends entirely on Tesla's stock movement and market sentiment toward electric vehicle innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
